Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.123EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.143EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.6.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.112.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.360EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.347EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.195EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.321EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.379EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.231EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.190EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.120EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.249EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.505EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.406EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.115EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used